Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kristen Barber

Physician Assistant Weston, FL Physician Assistant

NPI 1467990713 CMS profile 10484962

2133 N Commerce Pkwy, Weston, FL 33326

Open in the dashboard

General payments

$4,344

210 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kristen Barber of Weston, FL is reported in the CMS Open Payments database as having received $4,344 across 210 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,143 57
2024 General $787 35
2023 General $894 39
2022 General $721 36
2021 General $799 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristen Barber
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kristen Barber were reported at $1,143. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kristen Barber Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $799 $132 $37–$438 $132
2022 $721 $155 $48–$522 $149
2023 $894 $167 $52–$557 $160
2024 $787 $178 $55–$600 $164
2025 $1,143 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $703 35 payments
  2. GlaxoSmithKline, LLC. $539 21 payments
  3. Lilly USA, LLC $383 25 payments
  4. Novo Nordisk Inc $331 17 payments
  5. ViiV Healthcare Company $324 12 payments
  6. ITI, Inc. $284 15 payments
  7. AstraZeneca Pharmaceuticals LP $228 13 payments
  8. Antares Pharma, Inc. $209 7 payments
  9. Novartis Pharmaceuticals Corporation $203 9 payments
  10. Dexcom, Inc. $172 7 payments
  11. Other $967 49 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,344 210 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $649 31 payments
  2. TRELEGY ELLIPTA $539 21 payments
  3. Ozempic $315 16 payments
  4. RYBELSUS $275 14 payments
  5. MOUNJARO $239 16 payments
  6. CAPLYTA $239 13 payments
  7. XYOSTED $234 8 payments
  8. APRETUDE $204 8 payments
  9. TLANDO $163 5 payments
  10. NOCDURNA $163 5 payments
  11. Other $2,365 122 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

210 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record